Bumper Offer - Urjas oil Just @ Rs. 1
Olkem AM 40 Tablet is a prescription medicine that is available as a Tablet. Olkem AM 40 Tablet also has some secondary and off-label uses. These are listed below.
The optimal dosage of Olkem AM 40 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Olkem AM 40 Tablet include Upper respiratory tract infection. Some other side effects of Olkem AM 40 Tablet have been listed ahead. These side effects of Olkem AM 40 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
In addition, Olkem AM 40 Tablet's effect is Severe during pregnancy and Mild for lactating mothers. Further, the section on Olkem AM 40 Tablet related warnings talks about Olkem AM 40 Tablet's effects on the liver, heart and kidney.
Olkem AM 40 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Olkem AM 40 Tablet in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. Other conditions have been mentioned below in the Olkem AM 40 Tablet contraindications section.
Besides this, Olkem AM 40 Tablet may also have severe interaction with some medicines. Refer to the list below for further details.
In addition to these precautions, you may also note that Olkem AM 40 Tablet is not safe while driving, and is is not addictive in nature.
Olkem AM 40 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Olkem AM 40 Tablet is used -
Moderate
Mild
Is the use of Olkem AM 40 Tablet safe for pregnant women?
Olkem AM should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Olkem AM 40 Tablet safe during breastfeeding?
Side effects of Olkem AM for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Olkem AM 40 Tablet on the Kidneys?
Olkem AM has very mild side effects on the kidneys.
What is the effect of Olkem AM 40 Tablet on the Liver?
Olkem AM has very mild side effects on the liver.
What is the effect of Olkem AM 40 Tablet on the Heart?
Side effects of Olkem AM rarely affect the heart.
Olkem AM 40 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Olkem AM 40 Tablet unless your doctor advises you to do so -
Is this Olkem AM 40 Tablet habit forming or addictive?
No, you will not get addicted to Olkem AM 40 Tablet.
Interaction between Food and Olkem AM 40 Tablet
Taking Olkem AM 40 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Olkem AM 40 Tablet
Consumption of alcohol and Olkem AM 40 Tablet together may have severe effects on your health.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173